Enzymotec Stock Price (NASDAQ:ENZY)

Add to My Stocks
$9.1 $0.1 (1.11%) ENZY stock closing price Feb 22, 2017 (Closing)
YOUR DAILY UPDATE ON
ENZY
Enzymotec
22 FEB 2017
amigobulls logo
ENZY hand_up
ENZY vs S&P 500
Closing Price: Feb 22, 2017
ENZY
$9.1 ( 1.11%)
S&P 500
2362.8 ( -0.11%)
ENZY
52 Week Price Range
1 Year Return: 9.89%
Q3 Growth*
Poor
Profitable ?
Yes
net image
2016 Q3 Net Profit
4.8%
PE Valuation
Expensive*
home image
Rating
ENZY AVERAGE
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Enzymotec Snapshot Video

11 5 2

ENZY Stock Details

Prev Close* : $9.00
Market Cap:
$204.91M
Day Low: $9
52 Week Low: $5.20
Open: $9
Volume: 12973
Day High: $9.1
52 Week High: $9.32
Dividend:
N/A

Latest Stock Market News

Latest Articles

Enzymotec News - From Partners

ENZY Stockcharts

View ENZY PE ratio, PS ratio stocks charts and compare with peers.
ENZY Chart
Note: Compare Enzymotec stock price history with the index and industry peers.

Enzymotec Valuation

PE ratio
(price earnings ratio)
82.73
PS ratio (
price to sales ratio
)
4.11
PB ratio (
price to book ratio
)
1.5

Enzymotec Returns

ROE
(return on equity)
2%

Enzymotec Financial Ratios

Asset Turnover
0.3
Receivables Turnover
3.16

ENZY Industry Peers

Company Price Change (%)
Cellular Dynamics (ICEL)16.550.03 (0.18%)
Utah Medical Products (UTMD)61.650.2 (0.32%)
Teva Pharmaceutical (TEVA)35.970.68 (1.86%)
Neptune Tech. & Bio. (NEPT)1.080.06 (5.88%)
Acasti Pharma (ACST)1.280 (0%)
Abbott (ABT)45.010 (0%)
Sodastream International (SODA)47.070.39 (0.84%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
TG Therapeutics (TGTX)5.150.45 (9.57%)
Insys Therapeutics (INSY)13.480.83 (6.56%)
Omeros (OMER)11.590.13 (1.13%)
Enzymotec (ENZY)9.10.1 (1.11%)
OraSure (OSUR)11.080.08 (0.73%)
Rockwell Medical (RMTI)5.870.04 (0.69%)
Zeltiq (ZLTQ)55.650.37 (0.67%)
Top gainers from Medical Products industry
* As of Feb 22, 2017
CompanyPriceChange (%)
LeMaitre Vascular (LMAT)22.162.43 (9.88%)
Conatus Pharma (CNAT)4.820.25 (4.93%)
Chimerix (CMRX)5.440.24 (4.23%)
MacroGenics (MGNX)19.710.81 (3.95%)
GW Pharma (GWPH)125.174.26 (3.29%)
Agios Pharma (AGIO)48.991.41 (2.8%)
Cardiovascular Systems (CSII)27.540.63 (2.24%)
Top losers from Medical Products industry
* As of Feb 22, 2017

Enzymotec Financial Statements

income statement2015201420132012
Net Sales Or Revenues50.39M47.1M64.97M37.87M
Net Income6.68M7.83M11.39M4.78M
Total Operating Expense24.57M21.48M21.09M-
view Enzymotec Ltd income statement
balance sheet201520142013
Total Assets148.92M138.25M136.37M
Total Liabilities12.2M9.97M18.47M
Shareholders Equity136.71M128.27M117.9M
view Enzymotec Ltd balance sheet
cash flow statement201520142013
Net Increase (Decrease) In Assets Liabilities1.17M-9.62M-6.17M
Net Cash From (Used By) Operating Activities11.19M1.96M7.39M
Increase (Decrease) In Prop Plant And Equipment-2.85M-6.36M-4.87M
view Enzymotec Ltd cashflow statement

Enzymotec Ltd Stock News - Partner Headlines

Enzymotec Stock Message Board

Enzymotec stock lost 0.56 %, and the last close price as of 21 Feb, 2017 is 9 for ENZY stock. Enzymotec market capitalization is 203.77M and it represents the total market value of ENZY stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Enzymotec stock analysis.

The terms stocks and shares mean the same thing. For Ex: Enzymotec stock price and Enzymotec share price mean the same thing. 10141 ENZY shares were traded yesterday, and Enzymotec stock chart shows that the ENZY stock quote hit a day high of 9.1 and day low of 9. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Enzymotec stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.